Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eustratios Bananis

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Annals of the Rheumatic Diseases|October 19, 2014
Response to: 'Is there a need for new thresholds to define remission and low disease activity by Disease Activity Score 28 calculated with C reactive protein? Real life data from a local registry' by Favalli et alRoy Fleischmann, Eustratios Bananis
The Journal of Rheumatology|November 3, 2018
Dr. Charles-Schoeman and E. Bananis ReplyChristina Charles-Schoeman, Eustratios Bananis
Analytical Biochemistry|May 23, 2002
Immunofluorescence microchamber technique for characterizing isolated organellesJohn W Murray, Eustratios Bananis, Allan W Wolkoff
Expert Review of Pharmacoeconomics & Outcomes Research|July 21, 2012
When is switching warranted among biologic therapies in rheumatoid arthritis?Alan Reynolds, Andrew S Koenig, Eustratios Bananis, et al.
RMD Open|May 14, 2016
Relationship between clinical and patient-reported outcomes in a phase 3 trial of tofacitinib or MTX in MTX-naïve patients with rheumatoid arthritisRoy Fleischmann, Vibeke Strand, Bethanie Wilkinson, et al.
Journal of Cell Science|May 22, 2003
Regulation of early endocytic vesicle motility and fission in a reconstituted systemEustratios Bananis, John W Murray, Richard J Stockert, et al.
The Journal of Rheumatology|June 17, 2015
Predictors of Clinical Remission under Anti-tumor Necrosis Factor Treatment in Patients with Ankylosing Spondylitis: Pooled Analysis from Large Randomized Clinical TrialsXenofon Baraliakos, Andrew S Koenig, Heather Jones, et al.
Rheumatology (Oxford, England)|June 8, 2014
Short-term efficacy of etanercept plus methotrexate vs combinations of disease-modifying anti-rheumatic drugs with methotrexate in established rheumatoid arthritisRoy Fleischmann, Andrew S Koenig, Annette Szumski, et al.
Traffic (Copenhagen, Denmark)|June 1, 2006
PKCzeta is required for microtubule-based motility of vesicles containing the ntcp transporterSouvik Sarkar, Eustratios Bananis, Sangeeta Nath, et al.
RMD Open|March 4, 2017
DAS28-CRP and DAS28-ESR cut-offs for high disease activity in rheumatoid arthritis are not interchangeableRoy M Fleischmann, Désirée van der Heijde, Philip V Gardiner, et al.
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Annals of the Rheumatic Diseases|October 19, 2014
Response to: 'Is there a need for new thresholds to define remission and low disease activity by Disease Activity Score 28 calculated with C reactive protein? Real life data from a local registry' by Favalli et alRoy Fleischmann, Eustratios Bananis
The Journal of Rheumatology|November 3, 2018
Dr. Charles-Schoeman and E. Bananis ReplyChristina Charles-Schoeman, Eustratios Bananis
Analytical Biochemistry|May 23, 2002
Immunofluorescence microchamber technique for characterizing isolated organellesJohn W Murray, Eustratios Bananis, Allan W Wolkoff
Expert Review of Pharmacoeconomics & Outcomes Research|July 21, 2012
When is switching warranted among biologic therapies in rheumatoid arthritis?Alan Reynolds, Andrew S Koenig, Eustratios Bananis, et al.
RMD Open|May 14, 2016
Relationship between clinical and patient-reported outcomes in a phase 3 trial of tofacitinib or MTX in MTX-naïve patients with rheumatoid arthritisRoy Fleischmann, Vibeke Strand, Bethanie Wilkinson, et al.
Journal of Cell Science|May 22, 2003
Regulation of early endocytic vesicle motility and fission in a reconstituted systemEustratios Bananis, John W Murray, Richard J Stockert, et al.
The Journal of Rheumatology|June 17, 2015
Predictors of Clinical Remission under Anti-tumor Necrosis Factor Treatment in Patients with Ankylosing Spondylitis: Pooled Analysis from Large Randomized Clinical TrialsXenofon Baraliakos, Andrew S Koenig, Heather Jones, et al.
Rheumatology (Oxford, England)|June 8, 2014
Short-term efficacy of etanercept plus methotrexate vs combinations of disease-modifying anti-rheumatic drugs with methotrexate in established rheumatoid arthritisRoy Fleischmann, Andrew S Koenig, Annette Szumski, et al.
Traffic (Copenhagen, Denmark)|June 1, 2006
PKCzeta is required for microtubule-based motility of vesicles containing the ntcp transporterSouvik Sarkar, Eustratios Bananis, Sangeeta Nath, et al.
RMD Open|March 4, 2017
DAS28-CRP and DAS28-ESR cut-offs for high disease activity in rheumatoid arthritis are not interchangeableRoy M Fleischmann, Désirée van der Heijde, Philip V Gardiner, et al.
Pageof 5